Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 401

1.

Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials.

O'Sullivan CC, Bradbury I, Campbell C, Spielmann M, Perez EA, Joensuu H, Costantino JP, Delaloge S, Rastogi P, Zardavas D, Ballman KV, Holmes E, de Azambuja E, Piccart-Gebhart M, Zujewski JA, Gelber RD.

J Clin Oncol. 2015 Jun 22. pii: JCO.2015.60.8620. [Epub ahead of print]

PMID:
26101239
2.

Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer.

Sparano JA, Zhao F, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE.

J Clin Oncol. 2015 Jun 15. pii: JCO.2015.60.9271. [Epub ahead of print]

PMID:
26077235
3.

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab as First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).

Rugo HS, Barry WT, Moreno-Aspitia A, Lyss AP, Cirrincione C, Leung E, Mayer EL, Naughton M, Toppmeyer D, Carey LA, Perez EA, Hudis C, Winer EP.

J Clin Oncol. 2015 Jun 8. pii: JCO.2014.59.5298. [Epub ahead of print]

PMID:
26056183
4.

Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries.

Zhu W, Perez EA, Hong R, Li Q, Xu B.

PLoS One. 2015 May 28;10(5):e0128345. doi: 10.1371/journal.pone.0128345. eCollection 2015.

5.

Protocol for suspected pediatric appendicitis limits computed tomography utilization.

Wagenaar AE, Tashiro J, Wang B, Curbelo M, Mendelson KL, Perez EA, Hogan AR, Neville HL, Sola JE.

J Surg Res. 2015 Apr 15. pii: S0022-4804(15)00423-0. doi: 10.1016/j.jss.2015.04.028. [Epub ahead of print]

PMID:
25979562
6.

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.

Wagner-Johnston ND, Sloan JA, Liu H, Kearns AE, Hines SL, Puttabasavaiah S, Dakhil SR, Lafky JM, Perez EA, Loprinzi CL.

Cancer. 2015 Apr 30. doi: 10.1002/cncr.29327. [Epub ahead of print]

PMID:
25930719
7.

Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors.

Necela BM, Crozier JA, Andorfer CA, Lewis-Tuffin L, Kachergus JM, Geiger XJ, Kalari KR, Serie DJ, Sun Z, Moreno-Aspitia A, O'Shannessy DJ, Maltzman JD, McCullough AE, Pockaj BA, Cunliffe HE, Ballman KV, Thompson EA, Perez EA.

PLoS One. 2015 Apr 30;10(4):e0127133. doi: 10.1371/journal.pone.0127133. eCollection 2015. No abstract available.

8.

Mechanism and mortality of pediatric aortic injuries.

Tashiro J, Hannay WM, Naves C, Allen CJ, Perez EA, Rey J, Sola JE.

J Surg Res. 2015 Mar 24. pii: S0022-4804(15)00316-9. doi: 10.1016/j.jss.2015.03.053. [Epub ahead of print]

PMID:
25918002
9.

Surgical management of bronchopulmonary malformations.

Wagenaar AE, Tashiro J, Hirzel A, Rodriguez LI, Perez EA, Hogan AR, Neville HL, Sola JE.

J Surg Res. 2015 Apr 1. pii: S0022-4804(15)00339-X. doi: 10.1016/j.jss.2015.03.080. [Epub ahead of print]

PMID:
25918001
10.

Hospital and procedure incidence of pediatric retained surgical items.

Wang B, Tashiro J, Perez EA, Lasko DS, Sola JE.

J Surg Res. 2015 Mar 24. pii: S0022-4804(15)00317-0. doi: 10.1016/j.jss.2015.03.054. [Epub ahead of print]

PMID:
25908101
11.

Resource utilization patterns of pediatric esophageal foreign bodies.

Teisch LF, Tashiro J, Perez EA, Mendoza F, Sola JE.

J Surg Res. 2015 Mar 24. pii: S0022-4804(15)00318-2. doi: 10.1016/j.jss.2015.03.055. [Epub ahead of print]

PMID:
25899146
12.

Hospital survival of aortic dissection in children.

Hua HU, Tashiro J, Allen CJ, Rey J, Perez EA, Sola JE.

J Surg Res. 2015 Jun 15;196(2):399-403. doi: 10.1016/j.jss.2015.03.030. Epub 2015 Mar 18.

PMID:
25881788
13.

Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101.

Borges S, Perez EA, Thompson EA, Radisky DC, Geiger XJ, Storz P.

Mol Cancer Ther. 2015 Jun;14(6):1306-16. doi: 10.1158/1535-7163.MCT-14-0945. Epub 2015 Apr 7.

PMID:
25852060
14.

Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer.

Lohmann AE, Chapman JA, Burnell MJ, Levine MN, Tsvetkova E, Pritchard KI, Gelmon KA, O'Brien P, Han L, Rugo HS, Albain KS, Perez EA, Vandenberg TA, Chalchal HI, Sawhney RP, Shepherd LE, Goodwin PJ.

Breast Cancer Res Treat. 2015 Apr;150(3):605-11. doi: 10.1007/s10549-015-3355-x. Epub 2015 Apr 2.

PMID:
25833209
16.

Folate receptor-α (FOLR1) expression and function in triple negative tumors.

Necela BM, Crozier JA, Andorfer CA, Lewis-Tuffin L, Kachergus JM, Geiger XJ, Kalari KR, Serie DJ, Sun Z, Aspita AM, O'Shannessy DJ, Maltzman JD, McCullough AE, Pockaj BA, Cunliffe HE, Ballman KV, Thompson EA, Perez EA.

PLoS One. 2015 Mar 27;10(3):e0122209. doi: 10.1371/journal.pone.0122209. eCollection 2015.

17.

Post-ECMO chest tube placement: A propensity score-matched survival analysis.

Tashiro J, Perez EA, Lasko DS, Sola JE.

J Pediatr Surg. 2015 May;50(5):793-7. doi: 10.1016/j.jpedsurg.2015.02.038. Epub 2015 Feb 19.

PMID:
25783367
18.

Determinants of survival and resource utilization for pediatric extracorporeal membrane oxygenation in the United States 1997-2009.

Bokman CL, Tashiro J, Perez EA, Lasko DS, Sola JE.

J Pediatr Surg. 2015 May;50(5):809-14. doi: 10.1016/j.jpedsurg.2015.02.042. Epub 2015 Feb 19.

PMID:
25783363
19.

Reply to E.A. Rakha et al.

Wolff AC, Hammond ME, Hicks DG, Allison KH, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Dowsett M, McShane LM, Hayes DF.

J Clin Oncol. 2015 Apr 10;33(11):1302-4. doi: 10.1200/JCO.2014.59.7559. Epub 2015 Mar 9. No abstract available.

PMID:
25753441
20.

Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).

Dueck AC, Singh J, Atherton P, Liu H, Novotny P, Hines S, Loprinzi CL, Perez EA, Tan A, Burger K, Zhao X, Diekmann B, Sloan JA; Alliance for Clinical Trials in Oncology.

Osteoporos Int. 2015 Jul;26(7):1971-7. doi: 10.1007/s00198-015-3091-4. Epub 2015 Mar 7.

PMID:
25749740
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk